Sfoglia per RIVISTA
NEUROLOGY AND THERAPY
Collezione ASL Asti

  

Items : 2

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1505-1506. doi: 10.1007/s40120-024-00648-z.

2024
ASL Asti

Barbanti P; Egeo G; Proietti S; d'Onofrio F; Aurilia C; Finocchi C; Di Clemente L; Zucco M; Doretti A; Messina S; Autunno M; Ranieri A; Carnevale A; Colombo B; Filippi M; Tasillo M; Rinalduzzi S; Querzani P; Sette G; Forino L; Zoroddu F; Robotti M; Valenza A; Camarda C; Borrello L; Aguggia M; Viticchi G; Tomino C; Fiorentini G; et alii...

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Jun;13(3):611-624. doi: 10.1007/s40120-024-00591-z. Epub 2024 Mar 7.

2024
ASL Asti

Borrello L; Aguggia M; Camarda C; Valenza A; Robotti M; Zoroddu F; Forino L; Sette G; Querzani P; Rinalduzzi S; Tasillo M; Filippi M; Colombo B; Carnevale A; Ranieri A; Autunno M; Messina S; Doretti A; Zucco M; Di Clemente L; Finocchi C; Aurilia C; d'Onofrio F; Proietti S; Egeo G; Barbanti P; Viticchi G; Tomino C; Fiorentini G; et alii...